Skip to main content
. 2021 Apr;9(8):635. doi: 10.21037/atm-20-7155

Figure 3.

Figure 3

Kaplan-Meier analysis of PFS in patients with (A) high and low mutation abundance or (B) 19Del or L858R mutation (95% CI). The dotted line indicates 95% CI. 19Del, exon 19 deletion; PFS, progression-free survival; CI, confidence interval.